Novartis and its CEO Vas Narasimhan have made a big deal about not increasing medicine prices to USA patients for the rest of 2018. This site is intended to disprove a lot of what Dr. Narasimhan and his company put out to the media and to give true context to their attempts to mislead the public. What Novartis fails to disclose is that it already price gouges the American patient by supplying Novartis medicines at hugely inflated prices compared to the rest of the world. Secondly, being a company based in Switzerland it holds these exorbitant profits in its Swiss bank accounts instead of the profits benefitting the American public. So in effect Novartis dexploits American people twice over.  The yellow buttons below link to the actual Novartis pricing files for both Diovan and Afinitor and prove just how greedy this company is when it comes to medicine pricing.